Responses
Immune cell therapies and immune cell engineering
Original research
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.